Clinical trial
Changes of Optical Quality During the Peak of the Covid-19 Pandemic From November 2022 to January 2023 in China
NCT05882383 is registered in ClinicalTrials.gov with Tianjin Eye Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Changes of Optical Quality During the Peak of the Covid-19 Pandemic From November 2022 to January 2023 in China
- Lead sponsor
- Tianjin Eye Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 25, 2022
- Completion date
- January 20, 2023
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
corneal wavefront aberration, sars-cov-2